Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
about
Efficacy of epidermal growth factor receptor inhibitors in combination with chemotherapy in advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer.Mutational profiling of non-small-cell lung cancer patients resistant to first-generation EGFR tyrosine kinase inhibitors using next generation sequencing.Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLCKnockdown of Immature Colon Carcinoma Transcript 1 Inhibits Proliferation and Promotes Apoptosis of Non-Small Cell Lung Cancer Cells.L-securinine inhibits the proliferation of A549 lung cancer cells and promotes DKK1 promoter methylation.mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy.Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients.Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis in Vitro and in Vivo.The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients.
P2860
Q36028888-6406AA78-6489-4F21-BEBB-9FAE401DD598Q37177513-A018CA50-AC46-4570-BB4D-B50353504858Q37641681-C1770ABD-9159-4352-B4F7-307FB6CCFC99Q37645002-D72C32B2-9BDC-4F70-9FEF-7F10F80DA99DQ39603767-DD477086-6847-4BC5-915B-10023B977016Q41701893-505CD21D-CECC-40F5-B852-A9AAF5F87201Q41911833-749C683C-6477-44E0-9E2F-E141C69CE44FQ49720695-82AAD503-C835-4FB7-902A-EF23C12F5E67Q55286443-9537732C-7D15-4F34-BC5D-21F4AF3E1136Q55314072-F21F759B-ED65-419C-9BD4-54FE53B9A2C0
P2860
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
@ast
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
@en
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
@nl
type
label
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
@ast
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
@en
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
@nl
prefLabel
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
@ast
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
@en
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
@nl
P2860
P3181
P1476
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
@en
P2093
Liangqing Ge
Ruizheng Shi
P2860
P304
10330-10339
P3181
P407
P577
2015-07-15T00:00:00Z